Literature DB >> 6631303

Oestrogen levels in the blood, not in the uterus, determine uterine eosinophilia and oedema.

A N Tchernitchin, P Galand.   

Abstract

This work was aimed at testing whether oestrogen-induced changes in the uterus are responsible for uterine eosinophil migration or whether the effect is due to a direct action of oestrogen on the eosinophils themselves. Uterine eosinophil migration in response to intraluminal administration of oestradiol-17 beta into one uterine horn was measured in the injected and in the untreated contralateral horns. Uterine genomic responses (luminal epithelial and myometrial hypertrophy and nucleolar enlargement), known to depend on the local intra-uterine oestrogen level, were measured to control for the absence of hormone recirculation to the uninjected horn. The effects of intravenously administered oestradiol were also determined. Intraluminal injection of 0 X 1 ng oestradiol had no effect on either horn. With 10 ng, only the injected horn exhibited the genomic responses while eosinophilia developed to the same extent in both horns. With 100 ng, the genomic responses and eosinophilia were identical in injected and in contralateral horns. The results show that eosinophil migration depends on systemic levels of oestrogen, thus indicating that it is due to an oestrogen-induced change in a property of eosinophil leukocytes rather than a change in the uterus itself. As water imbibition showed the same pattern of responses as eosinophilia, this lends further support to the hypothesis of a role for eosinophils in oestrogen-induced uterine oedema.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6631303     DOI: 10.1677/joe.0.0990123

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  13 in total

1.  Effect of various doses of catecholestrogens on uterine eosinophilia in the immature rat.

Authors:  P Baumann; A N Tchernitchin; G Grunert; P Ball
Journal:  Experientia       Date:  1986-02-15

2.  Effect of eosinophil-degranulating estrogens on spleen eosinophils and white pulp/red pulp ratio.

Authors:  A N Tchernitchin; W Carter; J Soto; P Baumann
Journal:  Agents Actions       Date:  1990-11

3.  The effect of CuIUD on estradiol receptor in the endometrium of rat--an autoradiographic study.

Authors:  Y G Liu; Y D Yang; G Q Huang; J Y Shen; P R Han; J H Li
Journal:  J Tongji Med Univ       Date:  1988

4.  p,p'-DDT is an estrogenic compound.

Authors:  S Bustos; J C Denegri; F Diaz; A N Tchernitchin
Journal:  Bull Environ Contam Toxicol       Date:  1988-10       Impact factor: 2.151

5.  Degranulatory action of estradiol on blood eosinophil leukocytes in vivo and in vitro.

Authors:  A N Tchernitchin; J Barrera; P Arroyo; M A Mena; K Vilches; G Grunert
Journal:  Agents Actions       Date:  1985-10

6.  Age-related changes in neuroprotection: is estrogen pro-inflammatory for the reproductive senescent brain?

Authors:  Farida Sohrabji; Shameena Bake
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

7.  Effect of ketotifen on the distribution and degranulation of uterine eosinophils in estrogen-treated rats.

Authors:  J Soto; A N Tchernitchin; P Poloni; G Voigt; B Caro; M Agurto
Journal:  Agents Actions       Date:  1989-11

8.  Daidzein-estrogen interaction in the rat uterus and its effect on human breast cancer cell growth.

Authors:  Leonardo Gaete; Andrei N Tchernitchin; Rodrigo Bustamante; Joan Villena; Igor Lemus; Manuel Gidekel; Gustavo Cabrera; Paola Astorga
Journal:  J Med Food       Date:  2012-12-10       Impact factor: 2.786

Review 9.  Estrogen-IGF-1 interactions in neuroprotection: ischemic stroke as a case study.

Authors:  Farida Sohrabji
Journal:  Front Neuroendocrinol       Date:  2014-05-29       Impact factor: 8.606

10.  Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats.

Authors:  Danielle K Lewis; Adam B Johnson; Shannon Stohlgren; Ashley Harms; Farida Sohrabji
Journal:  J Neuroimmunol       Date:  2008-03-06       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.